Glad we have Sullivan on board . I am sure the fact his fee for previous services is at risk causes him to keep a close eye on things here. Hopefully he has an ongoing dialogue with the SEC and that possibility is throwing a monkey wrench into the choices NR might take otherwise. Rosen was one of several that surfaced recently in filing a class action against OSTK. Looking forward to watching that war play out. The dirty tricks NR utilize to try and prevent losses to themselves are easily identified if you are on the lookout for them. Having Sullivan in our corner was a brilliant move by IPIX management IMHO. Go IPIX!!!
(3)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links